Page last updated: 2024-11-07

prednisone and Pituitary ACTH Hypersecretion

prednisone has been researched along with Pituitary ACTH Hypersecretion in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Pituitary ACTH Hypersecretion: A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Grillo, R1
Ritter, A1
Burow, A1
Vallelian, F1
Schaer, D1

Reviews

1 review available for prednisone and Pituitary ACTH Hypersecretion

ArticleYear
[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
    Praxis, 2014, Aug-20, Volume: 103, Issue:17

    Topics: Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Femoral Neck Fractures

2014

Other Studies

1 other study available for prednisone and Pituitary ACTH Hypersecretion

ArticleYear
Case report of possible iatrogenic Cushing's disease with low-dose prednisone to treat dermal filler hypersensitivity.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:12

    Topics: Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hypersensitivity; Iatrogenic Dise

2022